172 related articles for article (PubMed ID: 11137330)
1. Application and factor analysis of the menopause rating scale [MRS] in a post-marketing surveillance study of Climen.
Schneider HP; Rosemeier HP; Schnitker J; Gerbsch S; Turck R
Maturitas; 2000 Dec; 37(2):113-24. PubMed ID: 11137330
[TBL] [Abstract][Full Text] [Related]
2. The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study.
Heinemann LA; DoMinh T; Strelow F; Gerbsch S; Schnitker J; Schneider HP
Health Qual Life Outcomes; 2004 Nov; 2():67. PubMed ID: 15555079
[TBL] [Abstract][Full Text] [Related]
3. The role of antiandrogens in hormone replacement therapy.
Schneider HP
Climacteric; 2000 Dec; 3 Suppl 2():21-7. PubMed ID: 11379383
[TBL] [Abstract][Full Text] [Related]
4. [Clinical experiences with Climen in peri- and postmenopausal women].
Husmann F
Zentralbl Gynakol; 1997; 119(3):123-7. PubMed ID: 9173770
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness, tolerability and acceptance of an oral estradiol/levonorgestrel formulation for the treatment of menopausal complaints: a non-interventional observational study over six cycles of 28 days.
Rouskova D; Mittmann K; Schumacher U; Dietrich H; Zimmermann T
Gynecol Endocrinol; 2014 Oct; 30(10):712-6. PubMed ID: 24905727
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS).
Glaser R; York AE; Dimitrakakis C
Maturitas; 2011 Apr; 68(4):355-61. PubMed ID: 21177051
[TBL] [Abstract][Full Text] [Related]
7. Endocrine effects in Asian postmenopausal women treated with SH D 461 M and Prempak-C.
Goh HH; McCarthy TG; Dramusic V; Costales A; Junge W; Ratnam SS
Maturitas; 1994 Dec; 20(2-3):165-73. PubMed ID: 7715469
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women.
Saure A; Planellas J; Poulsen HK; Jaszczak P
Maturitas; 2000 Feb; 34(2):133-42. PubMed ID: 10714908
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness, tolerability and acceptance of a low-dosed estradiol/dienogest formulation (Lafamme 1 mg/2 mg) for the treatment of menopausal complaints: a non-interventional observational study over 6 cycles of 28 days.
Rouskova D; Mittmann K; Schumacher U; Dietrich H; Zimmermann T
Gynecol Endocrinol; 2015 Jul; 31(7):560-4. PubMed ID: 26217921
[TBL] [Abstract][Full Text] [Related]
10. [Acceptability of continuous combined versus cyclical HRT: a French multicentric randomized clinical study].
Drapier-Faure E; Azoulay C; Abramovici Y
Gynecol Obstet Fertil; 2005; 33(7-8):498-504. PubMed ID: 16005674
[TBL] [Abstract][Full Text] [Related]
11. Effect of different hormone replacement therapy regimens on circadian blood pressure profile and active renin in postmenopausal women.
Zacharieva S; Kirilov G; Kalinov K; Shigarminova R; Nachev E; Orbetzova M; Atanassova I
Gynecol Endocrinol; 2002 Dec; 16(6):461-7. PubMed ID: 12626033
[TBL] [Abstract][Full Text] [Related]
12. Frequency of symptoms, determinants of severe symptoms, validity of and cut-off score for Menopause Rating Scale (MRS) as a screening tool: a cross-sectional survey among midlife Nepalese women.
Chuni N; Sreeramareddy CT
BMC Womens Health; 2011 Jun; 11():30. PubMed ID: 21672198
[TBL] [Abstract][Full Text] [Related]
13. The Menopause Rating Scale (MRS): reliability of scores of menopausal complaints.
Schneider HP; Heinemann LA; Rosemeier HP; Potthoff P; Behre HM
Climacteric; 2000 Mar; 3(1):59-64. PubMed ID: 11910611
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and hormone use: new validation results of MRS scale.
Dinger J; Zimmermann T; Heinemann LA; Stoehr D
Health Qual Life Outcomes; 2006 May; 4():32. PubMed ID: 16737531
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and severity of menopause symptoms among perimenopausal and postmenopausal women aged 30-49 years in Gulele sub-city of Addis Ababa, Ethiopia.
Yisma E; Eshetu N; Ly S; Dessalegn B
BMC Womens Health; 2017 Dec; 17(1):124. PubMed ID: 29216870
[TBL] [Abstract][Full Text] [Related]
16. Assessing menopausal symptoms among healthy middle aged women with the Menopause Rating Scale.
Chedraui P; Aguirre W; Hidalgo L; Fayad L
Maturitas; 2007 Jul; 57(3):271-8. PubMed ID: 17329046
[TBL] [Abstract][Full Text] [Related]
17. The Menopause Rating Scale (MRS): comparison with Kupperman index and quality-of-life scale SF-36.
Schneider HP; Heinemann LA; Rosemeier HP; Potthoff P; Behre HM
Climacteric; 2000 Mar; 3(1):50-8. PubMed ID: 11910610
[TBL] [Abstract][Full Text] [Related]
18. Endocrine effects in Asian postmenopausal women, treated with SH D 461 M and Prempak-C.
Goh HH; McCarthy TG; Dramusic V; Costales A; Junge W; Ratnam SS
Maturitas; 1995 Jan; 21(1):17-25. PubMed ID: 7731378
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the presence and severity of menopausal symptoms among postmenopausal women screened for the metabolic syndrome.
Chedraui P; Pérez-López FR; Hidalgo L; Villacreses D; Domínguez A; Escobar GS; Genazzani AR; Simoncini T;
Gynecol Endocrinol; 2014; 30(12):918-24. PubMed ID: 25347000
[TBL] [Abstract][Full Text] [Related]
20. Coping with menopausal symptoms: An internet survey of Belgian postmenopausal women.
Depypere H; Pintiaux A; Desreux J; Hendrickx M; Neven P; Marchowicz E; Albert V; Leclercq V; Van den Branden S; Rozenberg S
Maturitas; 2016 Aug; 90():24-30. PubMed ID: 27282790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
